Breaking News Instant updates and real-time market news.

BYSI

BeyondSpring

$25.42

0.02 (0.08%)

07:24
09/25/18
09/25
07:24
09/25/18
07:24

BeyondSpring presents clinical data showing Plinabulin reduces thrombocytopenia

BeyondSpring presented clinical trial data on its novel lead asset, Plinabulin, during a poster presentation at theWorld Conference on Lung Cancer in Toronto, Canada. New data from the company's Phase 2 portion of the Phase 2/3 trial in Study 105 of Plinabulin was presented. Thrombocytopenia, a frequent side effect of chemotherapy, is a lowering of platelet counts that, when severe, leads to bleeding and anemia and can require transfusion with platelets, potentially resulting in a long ICU stay, as well as a high mortality rate. In a head-to-head Phase 2 trial comparing Plinabulin with Neulasta, a long-acting G-CSF, Plinabulin at 20 mg/m2 was shown to be effective in significantly reducing docetaxel-induced thrombocytopenia, while Neulasta did not show this benefit.

BYSI BeyondSpring
$25.42

0.02 (0.08%)

03/19/18
HCWC
03/19/18
NO CHANGE
HCWC
BeyondSpring 'hits ground running' with Phase 3 study, says H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis noted that BeyondSpring just announced the initiation of its Phase 3 Study 105 non-inferiority head-to-head study of Plinabulin compared to Neulasta for prevention of docetaxel chemotherapy induced neutropenia. Pantginis sees a possible Plinabulin NDA filing with the China Food and Drug Administration within one year, and maintained a Buy rating and $60 price target on BeyondSpring shares.
03/01/18
HCWC
03/01/18
NO CHANGE
Target $60
HCWC
Buy
BeyondSpring recent selloff unwarranted, says H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis views the 17.5% selloff in shares of BeyondSpring since the February 21 announced departure of CFO Richard Brand as unwarranted. After speaking to management, the analyst believes a new CFO will be a positive as the company moves closer to pivotal data and potential commercialization of Plinabulin. He keeps a Buy rating on BeyondSpring with a $60 price target.
12/05/17
GHSC
12/05/17
INITIATION
Target $56
GHSC
Buy
BeyondSpring initiated with a Buy at Seaport Global
Seaport Global analyst Vernon Bernardino initiated BeyondSpring with a Buy and $56 price target saying its lead drug, Plinabulin, is a differentiated standard in the potential treatment option for chemotherapy-induced neutropenia (CIN). He thinks Plinabulin could also play a key role in improving results with traditional cancer drugs and immunotherapies that are limited by their significant toxicities.
10/26/17
HCWC
10/26/17
NO CHANGE
Target $60
HCWC
Buy
BeyondSpring price target raised to $60 from $50 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for BeyondSpring to $60 saying new regulatory rules in China may accelerate Plinabulin approval. The CPC Central Committee and State Council of China's new regulatory guidelines should be beneficial to BeyondSpring by accelerating approval and extending intellectual property protection, Pantginis tells investors in a research note. He keeps a Buy rating o the shares.

TODAY'S FREE FLY STORIES

SE

Sea Limited

$25.41

-0.39 (-1.51%)

14:49
05/21/19
05/21
14:49
05/21/19
14:49
Options
Sea Limited options imply 14.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

AAPL

Apple

$187.49

4.43 (2.42%)

14:31
05/21/19
05/21
14:31
05/21/19
14:31
Periodicals
Apple expands keyboard repair program to include butterfly mechanism, Verge says »

Apple is updating its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

CC

Chemours

$23.77

1.35 (6.02%)

14:30
05/21/19
05/21
14:30
05/21/19
14:30
Options
5K Chemours Oct 16 - 20 put spreads bought for 92c as shares rally »

5K Chemours Oct 16 - 20…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
05/21/19
05/21
14:25
05/21/19
14:25
Conference/Events
Cowen biotechnology analysts to hold an analyst/industry conference call »

Biotechnology Analysts…

QRVO

Qorvo

$62.14

0.84 (1.37%)

14:22
05/21/19
05/21
14:22
05/21/19
14:22
Recommendations
Qorvo analyst commentary at Oppenheimer »

Qorvo could be first to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PED

PEDEVCO Corp.

$2.02

-0.06 (-2.88%)

14:21
05/21/19
05/21
14:21
05/21/19
14:21
Hot Stocks
PEDEVCO Corp. announces sale of stock to SK Energy, two unaffiliated investors »

PEDEVCO Corp. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PED

PEDEVCO Corp.

$2.02

-0.06 (-2.88%)

14:20
05/21/19
05/21
14:20
05/21/19
14:20
Hot Stocks
Breaking Hot Stocks news story on PEDEVCO Corp. »

PEDEVCO Corp. trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
05/21/19
05/21
14:17
05/21/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
05/21/19
05/21
14:16
05/21/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$127.09

0.9 (0.71%)

, AAPL

Apple

$187.52

4.46 (2.44%)

14:15
05/21/19
05/21
14:15
05/21/19
14:15
Periodicals
Microsoft cuts Huawei laptop from store, Verge says »

According to a story from…

MSFT

Microsoft

$127.09

0.9 (0.71%)

AAPL

Apple

$187.52

4.46 (2.44%)

HPQ

HP Inc.

$19.55

0.6 (3.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 03

    Jun

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 11

    Jun

  • 23

    Jun

  • 06

    Aug

BCRX

BioCryst

$3.45

-3.95 (-53.38%)

14:13
05/21/19
05/21
14:13
05/21/19
14:13
Recommendations
BioCryst analyst commentary at JMP Securities »

BioCryst pullback an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

XRX

Xerox

$32.83

0.705 (2.19%)

14:12
05/21/19
05/21
14:12
05/21/19
14:12
Hot Stocks
Xerox shareholders approve holding company reorganization »

Xerox announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

YELP

Yelp

$32.36

0.65 (2.05%)

14:10
05/21/19
05/21
14:10
05/21/19
14:10
Options
Bullish option flow in Yelp »

Bullish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 27

    Jun

PED

PEDEVCO Corp.

$2.02

-0.06 (-2.88%)

13:51
05/21/19
05/21
13:51
05/21/19
13:51
Hot Stocks
Breaking Hot Stocks news story on PEDEVCO Corp. »

PEDEVCO Corp. trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIR

Circor

$42.87

12.23 (39.92%)

13:47
05/21/19
05/21
13:47
05/21/19
13:47
Hot Stocks
Breaking Hot Stocks news story on Circor 

CIRCOR trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYDS

Payment Data Systems

$2.30

0.18 (8.49%)

13:46
05/21/19
05/21
13:46
05/21/19
13:46
Hot Stocks
Payment Data Systems jumps over 7% after announcing pact with Pineapple Payments »

Earlier on Tuesday,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 30

    May

  • 11

    Jun

FLR

Fluor

$29.94

0.48 (1.63%)

13:45
05/21/19
05/21
13:45
05/21/19
13:45
Options
Fluor call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

  • 13

    Jun

GOOD

Gladstone

$21.61

0.165 (0.77%)

13:41
05/21/19
05/21
13:41
05/21/19
13:41
Recommendations
Gladstone analyst commentary at Ladenburg »

Gladstone's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

CIR

Circor

$42.96

12.32 (40.21%)

, CR

Crane

$83.27

-1.62 (-1.91%)

13:33
05/21/19
05/21
13:33
05/21/19
13:33
Hot Stocks
Circor again rejects Crane bid, says it 'substantially' undervalues company »

Circor International…

CIR

Circor

$42.96

12.32 (40.21%)

CR

Crane

$83.27

-1.62 (-1.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIR

Circor

$42.96

12.32 (40.21%)

, CR

Crane

$83.27

-1.62 (-1.91%)

13:30
05/21/19
05/21
13:30
05/21/19
13:30
Hot Stocks
Breaking Hot Stocks news story on Circor, Crane »

Circor 'reiterates…

CIR

Circor

$42.96

12.32 (40.21%)

CR

Crane

$83.27

-1.62 (-1.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MET

MetLife

$48.03

0.52 (1.09%)

13:30
05/21/19
05/21
13:30
05/21/19
13:30
Periodicals
MetLife in talks to sell central European assets to Generali, Bloomberg says »

The business being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

  • 18

    Jun

  • 18

    Jun

PXD

Pioneer Natural

$157.52

3.29 (2.13%)

13:26
05/21/19
05/21
13:26
05/21/19
13:26
Hot Stocks
Pioneer Natural backs Q2 Permian production view 313-328 MBOEPD »

Backs Q2 Permian oil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 07

    Aug

CMCSA

Comcast

$43.15

0.37 (0.86%)

, CMCSK

Comcast

$0.00

(0.00%)

13:25
05/21/19
05/21
13:25
05/21/19
13:25
Periodicals
Comcast working on device similar to Amazon Echo, focused on health, CNBC says »

Comcast (CMCSA, CMCSK) is…

CMCSA

Comcast

$43.15

0.37 (0.86%)

CMCSK

Comcast

$0.00

(0.00%)

AMZN

Amazon.com

$1,853.86

-4.95 (-0.27%)

GOOG

Alphabet

$1,151.98

13.65 (1.20%)

GOOGL

Alphabet Class A

$1,157.99

12.71 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 03

    Jun

  • 05

    Jun

  • 19

    Jun

  • 19

    Jun

  • 24

    Jun

  • 27

    Oct

CIR

Circor

$43.01

12.37 (40.37%)

13:25
05/21/19
05/21
13:25
05/21/19
13:25
Hot Stocks
Breaking Hot Stocks news story on Circor »

CIRCOR trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PXD

Pioneer Natural

$157.52

3.29 (2.13%)

13:25
05/21/19
05/21
13:25
05/21/19
13:25
Hot Stocks
Pioneer Natural sees FY19 Permian production 320-335 MBOEPD »

Sees FY19 cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 07

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.